logo

For the Inventor, By the Inventor

Boulder, CO, United States of America

Stephen Federowicz

USPTO Granted Patents = 17 

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 57(Granted Patents)


Company Filing History:

goldMedal17 out of 166 
 
Inscripta, Inc.
 patents

Years Active: 2019-2023

Loading Chart...
17 patents (USPTO):Explore Patents
1. 11555184 - Methods for identifying selective binding pairs (2023-01-17),
2. 11473214 - Automated instrumentation for production of T-cell receptor peptide libraries (2022-10-18),
3. 11396718 - Automated instrumentation for production of T-cell receptor peptide libraries (2022-07-26),
4. 11359187 - Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells (2022-06-14),
5. 11293117 - Automated instrumentation for production of T-cell receptor peptide libraries (2022-04-05),
6. 11286471 - Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells (2022-03-29),
7. 11198857 - Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells (2021-12-14),
8. 11104890 - Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells (2021-08-31),
9. 11008557 - Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells (2021-05-18),
10. 10774446 - Automated instrumentation for production of T-cell receptor peptide libraries (2020-09-15),
11. 10774324 - Automated instrumentation for production of peptide libraries (2020-09-15),
12. 10711374 - Automated instrumentation for production of T-cell receptor peptide libraries (2020-07-14),
13. 10676842 - Automated instrumentation for production of T-cell receptor peptide libraries (2020-06-09),
14. 10557216 - Automated instrumentation for production of T-cell receptor peptide libraries (2020-02-11),
15. 10526598 - Methods for identifying T-cell receptor antigens (2020-01-07),

Title: The Innovative Mind of Stephen Federowicz

Introduction

Stephen Federowicz is a prominent inventor based in Boulder, CO, known for his significant contributions to the field of biotechnology. With a remarkable portfolio of 17 patents, his work centers around advanced methodologies for identifying binding partners and creating T-cell receptor peptide libraries, which play a crucial role in immunotherapy and precision medicine.

Latest Patents

Among his latest innovations, Stephen has developed two notable patents. The first is a method for identifying selective binding pairs, which involves using cell surface display libraries. This method allows engineered peptides to be expressed on cell surfaces, facilitating the identification of peptides that specifically bind to desired targets. The engineered peptides are expressed under conditions that ensure both secretion and display, paving the way for the identification of potential binding pairs.

The second patent focuses on automated instrumentation for producing T-cell receptor peptide libraries. This invention represents a significant advancement in the creation of cell surface display libraries, where the engineered peptides serve as antigens binding to T-cell receptors. The method illustrates an automated approach that enables precise identification of potential antigens and binding regions, enhancing the efficiency of immunological research.

Career Highlights

Stephen Federowicz is currently associated with Inscripta, Inc., a leading company in the field of genomic engineering. His expertise and innovative mindset contribute significantly to the company's research and development efforts in creating cutting-edge technologies for genomic editing and biotechnology solutions.

Collaborations

Throughout his career, Stephen has had the privilege of collaborating with talented individuals, including his coworkers Deanna Church and Michael Graige. These partnerships facilitate a dynamic exchange of ideas and expertise, driving forward the innovations that impact the field of biotechnology.

Conclusion

Stephen Federowicz exemplifies the spirit of innovation in biotechnology through his impressive array of patents and contributions to the scientific community. His work at Inscripta, Inc. continues to inspire advancements in immunology and personalized medicine, showcasing the vital role of inventors in shaping the future of science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…